The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Sladek FM. What are nuclear receptor ligands? Mol. Cell Endocrinol.334(1–2),3–13 (2010).
  MedlineGoogle Scholar
• 2  Burris TP. Nuclear hormone receptors for heme: REV-ERBα and REV-ERBβ are ligand-regulated components of the mammalian clock. Mol. Endocrinol.22(7),1509–1520 (2008).
  Medline CASGoogle Scholar
• 3  Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell83(6),835–839 (1995).
  Medline CASGoogle Scholar
• 4  Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell83(6),841–850 (1995).
  Medline CASGoogle Scholar
• 5  Raghuram S, Stayrook KR, Huang P et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ. Nat. Struct. Mol. Biol.14(12),1207–1213 (2007).▪▪ In conjunction with [6], these studies identified heme as an endogenous physiological ligand for the orphan nuclear receptors REV-ERBα and β.
  Medline CASGoogle Scholar
• 6  Yin L, Wu N, Curtin JC et al. REV-ERBα, a heme sensor that coordinates metabolic and circadian pathways. Science318(5857),1786–1789 (2007).▪▪ In conjunction with [5], these studies identified heme as an endogenous physiological ligand for the orphan nuclear receptors REV-ERBα and β.
  Medline CASGoogle Scholar
• 7  Becker-Andre M, Andre E, DeLamarter JF. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem. Biophys. Res. Commun.194(3),1371–1379 (1993).
  Medline CASGoogle Scholar
• 8  Giguere V, Tini M, Flock G et al. Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors. Genes Dev.8(5),538–553 (1994).
  Medline CASGoogle Scholar
• 9  Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-André M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol.8(6),757–770 (1994).
  Medline CASGoogle Scholar
• 10  Hirose T, Smith RJ, Jetten AM. RORγ: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem. Biophys. Res. Commun.205(3),1976–1983 (1994).
  Medline CASGoogle Scholar
• 11  Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal.7,e003 (2009).
  MedlineGoogle Scholar
• 12  Wang Y, Kumar N, Solt LA et al. Modulation of retinoic acid receptor-related orphan receptor α and γ activity by 7-oxygenated sterol ligands. J. Biol. Chem.285(7),5013–5025 (2010).
  Medline CASGoogle Scholar
• 13  Burke L, Downes M, Carozzi A, Giguère V, Muscat GE. Transcriptional repression by the orphan steroid receptor RVR/REV-ERBβ is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis. Nucleic Acids Res.24(18),3481–3489 (1996).
  Medline CASGoogle Scholar
• 14  Downes M, Burke LJ, Bailey PJ, Muscat GE. Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with REV-ERBAα and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res.24(22),4379–4386 (1996).
  Medline CASGoogle Scholar
• 15  Zamir I, Harding HP, Atkins GB et al. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell Biol.16(10),5458–5465 (1996).
  Medline CASGoogle Scholar
• 16  Harding HP, Lazar MA. The orphan receptor REV-ERBAα activates transcription via a novel response element. Mol. Cell Biol.13(5),3113–3121 (1993).
  Medline CASGoogle Scholar
• 17  Harding HP, Lazar MA. The monomer-binding orphan receptor REV-ERB represses transcription as a dimer on a novel direct repeat. Mol. Cell Biol.15(9),4791–4802 (1995).
  Medline CASGoogle Scholar
• 18  Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell134(5),728–742 (2008).
  Medline CASGoogle Scholar
• 19  DeBruyne JP, Weaver DR, Reppert SM. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat. Neurosci.10(5),543–545 (2007).
  Medline CASGoogle Scholar
• 20  Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma113(3),103–112 (2004).
  MedlineGoogle Scholar
• 21  Duez H, Pavlic M, Lewis GF. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atheroscler. Suppl.9(2),33–38 (2008).
  Medline CASGoogle Scholar
• 22  Guillaumond F, Dardente H, Giguère V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J. Biol. Rhythms20(5),391–403 (2005).
  Medline CASGoogle Scholar
• 23  Sato TK, Panda S, Miraglia LJ et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron43(4),527–537 (2004).▪ Study suggesting that the opposing activities of the nuclear receptors RORa and REV-ERBa are important in the maintenance of the core mammalian circadian clock.
  Medline CASGoogle Scholar
• 24  Akashi M, Takumi T. The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1. Nat. Struct. Mol. Biol.12(5),441–448 (2005).▪▪ Study identified RORα as a functional component of the cell-autonomous core circadian clock.
  Medline CASGoogle Scholar
• 25  Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component, NPAS2, as a REV-ERB{α}/ROR{α} target gene. J. Biol. Chem.285,35386–35392 (2010).
  Medline CASGoogle Scholar
• 26  Preitner N, Damiola F, Molina L et al. The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell110(2),251–260 (2002).▪▪ Study identified REV-ERBα as being an integral part of the regulation of the circadian clock.
  Medline CASGoogle Scholar
• 27  Masana MI, Sumaya IC, Becker-Andre M, Dubocovich ML. Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORβ knockout. Am. J. Physiol. Regul. Integr. Comp. Physiol.292(6),R2357–R2367 (2007).
  Medline CASGoogle Scholar
• 28  Schaeren-Wiemers N, André E, Kapfhammer JP, Becker-André M. The ExDression pattern of the orphan nuclear receptor RORβ in the developing and adult rat nervous system suggests a role in the processing of sensory information and in circadian rhythm. Eur. J. Neurosci.9(12),2687–2701 (1997).
  Medline CASGoogle Scholar
• 29  Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, Kay SA. Redundant function of REV-ERBα and β and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet.4(2),e1000023 (2008).
  MedlineGoogle Scholar
• 30  Ando H, Yanagihara H, Hayashi Y et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology146(12),5631–5636 (2005).
  Medline CASGoogle Scholar
• 31  Panda S, Antoch MP, Miller BH et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell109(3),307–320 (2002).
  Medline CASGoogle Scholar
• 32  Hamilton BA, Frankel WN, Kerrebrock AW et al. Disruption of the nuclear hormone receptor RORα in staggerer mice. Nature379(6567),736–739 (1996).
  Medline CASGoogle Scholar
• 33  Vu-Dac N, Gervois P, Grötzinger T et al. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORα. J. Biol. Chem.272(36),22401–22404 (1997).
  Medline CASGoogle Scholar
• 34  Raspe E, Duez H, Gervois P et al. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORα. J. Biol. Chem.276(4),2865–2871 (2001).
  Medline CASGoogle Scholar
• 35  Mamontova A, Séguret-Macé S, Esposito B et al. Severe atherosclerosis and hypoαlipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORα. Circulation98(24),2738–2743 (1998).
  Medline CASGoogle Scholar
• 36  Lau P, Fitzsimmons RL, Raichur S, Wang SC, Lechtken A, Muscat GE. The orphan nuclear receptor, RORα, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J. Biol. Chem.283(26),18411–18421 (2008).
  Medline CASGoogle Scholar
• 37  Kang HS, Angers M, Beak JY et al. Gene expression profiling reveals a regulatory role for RORα and RORγ in Phase I and Phase II metabolism. Physiol. Genomics31(2),281–294 (2007).
  Medline CASGoogle Scholar
• 38  Wada T, Kang HS, Angers M et al. Identification of oxysterol 7α-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor α (RORα) (NR1F1) target gene and a functional cross-talk between RORα and liver X receptor (NR1H3). Mol. Pharmacol.73(3),891–899 (2008).
  Medline CASGoogle Scholar
• 39  Kharitonenkov A, Shiyanova TL, Koester A et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest.115(6),1627–1635 (2005).
  Medline CASGoogle Scholar
• 40  Mayer D. The circadian rhythm of synthesis and catabolism of cholesterol. Arch. Toxicol.36(3–4),267–276 (1976).
  Medline CASGoogle Scholar
• 41  Edwards PA, Muroya H, Gould RG. In vivo demonstration of the circadian thythm of cholesterol biosynthesis in the liver and intestine of the rat. J. Lipid Res.13(3),396–401 (1972).
  Medline CASGoogle Scholar
• 42  Chopra AR, Louet JF, Saha P et al. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke’s disease. Science322(5906),1395–1399 (2008).▪ Identified G6Pase as an ROR target gene, and linked ROR transcriptional activity with glucose metabolism.
  Medline CASGoogle Scholar
• 43  Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab.5(6),426–437 (2007).
  Medline CASGoogle Scholar
• 44  Inagaki T, Dutchak P, Zhao G et al. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab.5(6),415–425 (2007).
  Medline CASGoogle Scholar
• 45  Duez H, Staels B. REV-ERBα: an integrator of circadian rhythms and metabolism. J. Appl. Physiol.107(6),1972–1980 (2009).
  Medline CASGoogle Scholar
• 46  Chomez P, Neveu I, Mansén A et al. Increased cell death and delayed development in the cerebellum of mice lacking the REV-ERB(α) orphan receptor. Development127(7),1489–1498 (2000).
  Medline CASGoogle Scholar
• 47  Raspe E, Duez H, Mansén A et al. Identification of REV-ERBα as a physiological repressor of apoC-III gene transcription. J. Lipid Res.43(12),2172–2179 (2002).
  Medline CASGoogle Scholar
• 48  Shachter NS. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol.12(3),297–304 (2001).
  Medline CASGoogle Scholar
• 49  Wang J, Yin L, Lazar MA. The orphan nuclear receptor REV-ERBα regulates circadian expression of plasminogen activator inhibitor type 1. J. Biol. Chem.281(45),33842–33848 (2006).
  Medline CASGoogle Scholar
• 50  Anzulovich A, Mir A, Brewer M, Ferreyra G, Vinson C, Baler R. Elovl3: a model gene to dissect homeostatic links between the circadian clock and nutritional status. J. Lipid Res.47(12),2690–2700 (2006).
  Medline CASGoogle Scholar
• 51  Vu-Dac N, Chopin-Delannoy S, Gervois P et al. The nuclear receptors peroxisome proliferator-activated receptor α and REV-ERBα mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem.273(40),25713–25720 (1998).
  Medline CASGoogle Scholar
• 52  Estall JL, Ruas JL, Choi CS et al. PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/REV-ERB(α) axis. Proc. Natl Acad. Sci. USA106(52),22510–22515 (2009).
  Medline CASGoogle Scholar
• 53  Zheng J, Shan Y, Lambrecht RW, Donohue SE, Bonkovsky HL. Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin. Mol. Cell. Biochem.319(1–2),153–161 (2008).
  Medline CASGoogle Scholar
• 54  Ramakrishnan SN, Lau P, Burke LJ, Muscat GE. REV-ERBβ regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines. J. Biol. Chem.280(10),8651–8659 (2005).
  Medline CASGoogle Scholar
• 55  Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov.3(11),950–964 (2004).
  Medline CASGoogle Scholar
• 56  Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev.20(11),1405–1428 (2006).
  Medline CASGoogle Scholar
• 57  Wiesenberg I, Missbach M, Kahlen JP, Schräder M, Carlberg C. Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res.23(3),327–333 (1995).
  Medline CASGoogle Scholar
• 58  Kallen JA, Schlaeppi JM, Bitsch F et al. X-ray structure of the hRORα LBD at 1.63 Å: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα. Structure10(12),1697–1707 (2002).▪▪ Solved the first crystal structure of RORa’s ligand-binding domain (LBD) revealing cholesterol bound within the ligand-binding pocket.
  Medline CASGoogle Scholar
• 59  Kallen JA, Schlaeppi JM, Bitsch F, Delhon I, Fournier B. Crystal structure of the human RORα ligand binding domain in complex with cholesterol sulfate at 2.2 Å. J. Biol. Chem.279(14),14033–14038 (2004).▪ Through x-ray crystallography, this group identified cholesterol sulfate within the ligand-binding domain of RORα, and characterized it as another endogenous ligand for ROR.
  Medline CASGoogle Scholar
• 60  Stehlin C, Wurtz JM, Steinmetz A et al. X-ray structure of the orphan nuclear receptor RORβ ligand-binding domain in the active conformation. EMBO J.20(21),5822–5831 (2001).
  Medline CASGoogle Scholar
• 61  Stehlin-Gaon C, Willmann D, Zeyer D et al. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ. Nat. Struct. Biol.10(10),820–825 (2003).
  Medline CASGoogle Scholar
• 62  Wang Y, Kumar N, Crumbley C, Griffin PR, Burris TP. A second class of nuclear receptors for oxysterols: regulation of RORα and RORγ activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta.1801(8),917–923 (2010).
  Medline CASGoogle Scholar
• 63  Jin L, Martynowski D, Zheng S, Wada T, Xie W, Li Y. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ. Mol. Endocrinol.24(5),923–929 (2010).▪▪ Identified several hydroxycholesterols as endogenous ligands for RORγ through crystallographic methods.
  Medline CASGoogle Scholar
• 64  Adare A, Afanasiev S, Aidala C et al. Enhanced production of direct photons in Au + Au collisions at square root(S(NN)) = 200 GeV and implications for the initial temperature. Phys. Rev. Lett.104(13),132301 (2010).
  Medline CASGoogle Scholar
• 65  Pardee KI, Xu X, Reinking J et al. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBβ. PLoS Biol.7(2),e43 (2009).▪ Provided the crystal structure of REV-ERBβ when bound to heme.
  MedlineGoogle Scholar
• 66  Woo EJ, Jeong DG, Lim MY et al. Structural insight into the constitutive repression function of the nuclear receptor REV-ERBβ. J. Mol. Biol.373(3),735–744 (2007).
  Medline CASGoogle Scholar
• 67  Phelan CA, Gampe RT Jr, Lambert MH et al. Structure of REV-ERBα bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. Nat. Struct. Mol. Biol.17(7),808–814 (2010).▪ Provides the structure of the LBD of REV-ERBα when bound to the corepressor NCoR and suggests that REV-ERBα may be active in the absence of heme.
  Medline CASGoogle Scholar
• 68  Kumar N, Solt LA, Conkright JJ et al. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluorometh yl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-α/γ inverse agonist. Mol. Pharmacol.77(2),228–236 (2010).▪▪ Identifies the first synthetic ligand that modulates both RORα and RORγ activity through direct binding of the receptors, resulting in the modulation of the receptor’s ability to interact with transcriptional cofactor proteins.
  Medline CASGoogle Scholar
• 69  Houck KA, Borchert KM, Hepler CD et al. T0901317 is a dual LXR/FXR agonist. Mol. Genet. Metab.83(1–2),184–187 (2004).
  Medline CASGoogle Scholar
• 70  Mitro N, Vargas L, Romeo R, Koder A, Saez E. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett.581(9),1721–6172 (2007).
  Medline CASGoogle Scholar
• 71  Wang Y, Kumar N, Nuhant P et al. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ. ACS Chem. Biol.5(11),1029–1034 (2010).▪▪ Identified and characterized the first selective RORα/γ synthetic agonist.
  Medline CASGoogle Scholar
• 72  Kumar N, Kojetin DJ, Solt LA et al. Identification of ML176 (SR3335): a synthetic RORα selective inverse agonist. ACS Chem. Biol. DOI: 10.1021/cb1002762 (2010). (Epub ahead of print).
  Google Scholar
• 73  Meng QJ, McMaster A, Beesley S et al. Ligand modulation of REV-ERBα function resets the peripheral circadian clock in a phasic manner. J. Cell Sci.121(Pt. 21),3629–3635 (2008).▪▪ Identified and characterized the first selective REV-ERBα synthetic agonist, GSK4112.
  Medline CASGoogle Scholar
• 74  Fu M, Sun T, Bookout AL et al. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol. Endocrinol.19(10),2437–2450 (2005).
  Medline CASGoogle Scholar
• 75  Fontaine C, Rigamonti E, Pourcet B et al. The orphan nuclear receptor REV-ERBα is a peroxisome proliferator-activated receptor (PPAR) γ target gene and promotes PPARγ-induced adipocyte differentiation. J. Biol. Chem.278(39),37672–37680 (2003).
  Medline CASGoogle Scholar
• 76  Chawla A, Lazar MA. Induction of REV-ERBAα, an orphan receptor encoded on the opposite strand of the α-thyroid hormone receptor gene, during adipocyte differentiation. J. Biol. Chem.268(22),16265–16269 (1993).
  Medline CASGoogle Scholar
• 77  Duez H, Duhem C, Laitinen S et al. Inhibition of adipocyte differentiation by RORα. FEBS Lett.583(12),2031–2036 (2009).
  Medline CASGoogle Scholar
• 78  Austin S, Medvedev A, Yan ZH, Adachi H, Hirose T, Jetten AM. Induction of the nuclear orphan receptor RORγ during adipocyte differentiation of D1 and 3T3-L1 cells. Cell Growth Differ.9(3),267–276 (1998).
  Medline CASGoogle Scholar
• 79  Kumar N, Solt LA, Wang Y et al. Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology151(7),3015–3025 (2010).▪ Series of studies suggesting that heme, functioning as a REV-ERB ligand, is an important regulator of adipogenesis and that synthetic ligands can modulate adipogenesis and may be useful therapeutics for the treatment of metabolic diseases.
  Medline CASGoogle Scholar
• 80  Grant D, Yin L, Collins JL et al. GSK4112, a small-molecule chemical probe for the cell biology of the nuclear heme receptor REV-analogα. ACS Chem. Biol.5(10),925–932 (2010).
  Medline CASGoogle Scholar
• 81  Kojetin D, Wang Y, Kamenecka TM, Burris TP. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem. Biol.6(2),131–134 (2011).▪▪ Study that identified and characterized the first synthetic REV-ERB antagonist, SR8278.
  Medline CASGoogle Scholar
• 82  Lund J, Arendt J, Hampton SM, English J, Morgan LM. Postprandial hormone and metabolic responses amongst shift workers in Antarctica. J. Endocrinol.171(3),557–564 (2001).
  Medline CASGoogle Scholar
• 83  Kawachi I, Colditz GA, Stampfer MJ et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation92(11),3178–3182 (1995).
  Medline CASGoogle Scholar
• 84  Knutsson A, Hallquist J, Reuterwall C, Theorell T, Akerstedt T. Shiftwork and myocardial infarction: a case-control study. Occup. Environ. Med.56(1),46–50 (1999).
  Medline CASGoogle Scholar
• 85  Ellingsen T, Bener A, Gehani AA. Study of shift work and risk of coronary events. J. R. Soc. Promot. Health127(6),265–267 (2007).
  Medline CASGoogle Scholar
• 86  Hermansson J, Gillander Gådin K, Karlsson B, Lindahl B, Stegmayr B, Knutsson A. Ischemic stroke and shift work. Scand. J. Work Environ. Health33(6),435–943 (2007).
  MedlineGoogle Scholar
• 87  Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev.18(5),716–738 (2007).
  Google Scholar
• 88  Holterhus PM, Odendahl R, Oesingmann S et al. Classification of distinct baseline insulin infusion patterns in children and adolescents with Type I diabetes on continuous subcutaneous insulin infusion therapy. Diabetes Care30(3),568–573 (2007).
  MedlineGoogle Scholar
• 89  Wang Y, Kumar N, Solt LA et al. Modulation of ROR{α} and ROR{γ} activity by 7-oxygenated sterol ligands. J. Biol. Chem.285(1),5013–5025 (2009).▪▪ Study demonstrating that 7-oxygenated sterols function as high-affinity ligands for both RORα and RORγ leading to suppression of the transcriptional activity of the receptors.
  MedlineGoogle Scholar
• 90  Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis142(1),1–28 (1999).
  Medline CASGoogle Scholar
• 91  Brown AJ, Leong SL, Dean RT, Jessup W. 7-hydroperoxycholesterol and its products in oxidized low-density lipoprotein and human atherosclerotic plaque. J. Lipid Res.38(9),1730–1745 (1997).
  Medline CASGoogle Scholar
• 92  Gelissen IC, Brown AJ, Mander EL, Kritharides L, Dean RT, Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J. Biol. Chem.271(30),17852–17860 (1996).
  Medline CASGoogle Scholar
• 93  Zieden B, Kaminskas A, Kristenson M et al. Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler. Thromb. Vasc. Biol.19(4),967–971 (1999).
  Medline CASGoogle Scholar
• 94  Duez H, van der Veen JN, Duhem C et al. Regulation of bile acid synthesis by the nuclear receptor REV-ERBα. Gastroenterology135(2),689–698 (2008).
  Medline CASGoogle Scholar
• 95  Le Martelot G, Claudel T, Gatfield D et al. REV-ERBα participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol.7(9),e1000181 (2009).
  MedlineGoogle Scholar